Joel Yates
Education
Research InterestsRhoC effects on Cancer Metabolism
HobbiesCoaching and playing baseball, playing low level adult hockey, gardening, canning
Contact
|
Recent Publications
- Oliver, CR, MA Altemus, TM Westerhof, H Cheriyan, X Cheng, M Dziubinski, Z Wu, JA Yates, Aki Morikawa, J Heth, MG Castro, BM Leung, S Takayama, & SD Merajver. A platform for artificial intelligence bases identification of the extravasation potential of cancer cells into the brain metastatic niche. Lab on a Chip (2019). DOI: 10.1039/c8lc01387j
- Rosselli-Murai LK, Yates JA, Yoshida S, Bourg K, Ho KKY, White M, Prisby J, Tan X, Altemus M, Bao L, Wu Z-F, Veatch SL, Swanson JA, Merajver SD, Liu AP. Loss of PTEN Promotes Formation of Signaling-Capable Clathrin-Coated Pits. Journal of Cell Science (2018). DOI: 10.1242/jcs.208926
- Allen SG, Chen YC, Madden JM, Fournier CL, Altemus MA, Hiziroglu AB, Cheng Y-H, Wu ZF, Bao L, Yates JA, Yoon E, Merajver SD. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling. Scientific Reports volume 6, Article number: 39190 (2016). DOI: 10.1038/srep39190
- Wynn ML, Yates JA, Evans CR, Van Wassenhove L, Wu ZF, Bridges S, Bao L, Fournier C, Ashrafzadeh S, Merrins MJ, Satin LS, Schnell S, Burant CF, Merajver SD. RhoC is a Potent Regulator of Glutamine Metabolism and N-acetylaspartate Production in Inflammatory Breast Cancer Cells. Journal of Biological Chemistry (2016). DOI: 10.1074/jbc.M115.703959